Viewing data from:

NADOLOL

ANDA

NADOLOL | A203455 | INVAGEN PHARMACEUTICALS INC

3 strengths0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 4 NDCs

Highest NADAC/Unit

$0.3106

per ea

Lowest NADAC/Unit

$0.1825

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
76282034801NADOLOL 40 MG TABLET	$0.3106	EA	Generic	—	2026-06-17
69097086807NADOLOL 40 MG TABLET	$0.3106	EA	Generic	—	2026-06-17
76282034901NADOLOL 80 MG TABLET	$0.2645	EA	Generic	—	2026-06-17
76282034701NADOLOL 20 MG TABLET	$0.1825	EA	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain4 active DMFs1 inactive

4 active API suppliers hold Drug Master Files for this ingredient.

FERMION OYNADOLOL

DMF 62471986

SIGNA SA DE CVNADOLOL USP

DMF 74261988

MATRIX PHARMACORP PRIVATE LTDNADOLOL USP

DMF 249682011

BIOPHORE INDIA PHARMACEUTICALS PVT LTDNADOLOL

DMF 317352017

SYNCHEM CHEMICALS PRIVATE LTDInactiveNADOLOL

DMF 111921994

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

1 letter from Drugs@FDA

Date	Submission	Document
Dec 22, 2015	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (3)

Sort:

#001 — 20MG

0 patents0 exclusivities▴

TABLET;ORAL | Approved: Dec 18, 2015

No patent or exclusivity listings for this strength.

#002 — 40MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 18, 2015

#003 — 80MG

0 patents0 exclusivities▾

TABLET;ORAL | Approved: Dec 18, 2015